Form 4: VYNE Therapeutics Insider Reports Stock Transaction
Insider Transaction (Form 4)
RTW Fund Group GP, LLC and 1 other reported changes in beneficial ownership of VYNE Therapeutics Inc. common stock on July 29, 2026.
Summary
- Other acquisition/disposition: disposed of 133,290 Common Stock on July 29, 2026; holds 266,307 after (Indirect).
- Other acquisition/disposition: acquired 133,290 Pre-Funded Warrants (Right to Buy) on July 29, 2026; holds 8,949,719 after (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
RTW Fund Group GP, LLC — 10% owner
Roderick Wong — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-29 | Other acquisition/disposition | Common Stock | 133,290 | — | — | 266,307 |
| 2026-07-29 | Other acquisition/disposition | Pre-Funded Warrants (Right to Buy) | 133,290 | — | — | 8,949,719 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-29 | Other acquisition/disposition (133,290 shares) |
| 2026-07-29 | Other acquisition/disposition (133,290 shares) |
Keywords
insider transaction, Form 4, YARW, Yarrow Bioscience, Inc., neutral, RTW Fund Group GP, LLC, Roderick Wong
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.